Robert Harrington to Bilirubin
This is a "connection" page, showing publications Robert Harrington has written about Bilirubin.
Connection Strength
0.135
-
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I). Circulation. 2016 Dec 13; 134(24):1918-1930.
Score: 0.135